Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Digestive Diseases and Sciences
Published in: Digestive Diseases and Sciences 3/2003

01-03-2003

Helicobacter pylori Infection and High Dietary Salt Independently Induce Atrophic Gastritis and Intestinal Metaplasia in Commercially Available Outbred Mongolian Gerbils

Authors: Ingrid L. Bergin, Barbara J. Sheppard, James G. Fox

Published in: Digestive Diseases and Sciences | Issue 3/2003

Login to get access
Metadata
Title
Helicobacter pylori Infection and High Dietary Salt Independently Induce Atrophic Gastritis and Intestinal Metaplasia in Commercially Available Outbred Mongolian Gerbils
Authors
Ingrid L. Bergin
Barbara J. Sheppard
James G. Fox
Publication date
01-03-2003
Publisher
Kluwer Academic Publishers-Plenum Publishers
Published in
Digestive Diseases and Sciences / Issue 3/2003
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1023/A:1022524313355

Other articles of this Issue 3/2003

Digestive Diseases and Sciences 3/2003 Go to the issue

OriginalPaper

CASE REPORT: Verrucous Carcinoma of the Esophagus: Clinicopathophysiologic Features and Treatment of a Rare Entity

OriginalPaper

High Antigliadin IgG Titers in Laboratory Rabbits Fed a Wheat-Containing Diet: A Model for Celiac Disease?

OriginalPaper

CASE REPORT: Spontaneous Closure of Intrahepatic Portovenous Shunt in a Noncirrhotic Patient with Recurrent Encephalopathy

ReviewPaper

REVIEW: Overlap Syndromes of Autoimmune Hepatitis: What Is Known So Far

OriginalPaper

Immunolocalization and Expression of Kallistatin and Tissue Kallikrein in Human Inflammatory Bowel Disease

OriginalPaper

Hepatopulmonary Syndrome in Noncirrhotic Portal Hypertensive Patients
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits